Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL136478

SODIUM NITROPRUSSIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available

Basic Information

ChEMBL ID CHEMBL136478
Name SODIUM NITROPRUSSIDE
Phase Approved
Structure Type NONE
Therapeutic ✓ Yes
Parent Compound CHEMBL2097081
Active Moiety CHEMBL2097081

Known Names

Nipride Nipruss Nitropress Nitroprusside sodium NSC-755844 Sodium nitroprusside Sodium nitroprusside anhydrous Sodium nitroprusside dihydrate Sodium nitroprusside hydrate
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
9
Known Names
12
Indications
1
Mechanisms

Molecular Properties

215.9
MW (Da)

Drug Information

Molecule Type Small molecule
First Approval 1981
Availability Prescription
Chirality Achiral

Routes of Administration

Parenteral

Flags

Black Box Warning
USAN Stem -trop-

Extended Properties

Molecular Formula C5FeN6Na2O
MW 261.92

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Soluble guanylate cyclase activator ACTIVATOR Soluble guanylate cyclase

Indications

Heart Failure Hemorrhage Hypertension Anemia Psychotic Disorders Schizophrenia ST Elevation Myocardial Infarction Stress Disorders, Post-Traumatic Aging Cardiovascular Diseases Inflammation Sarcopenia

Drug Warnings

Black Box Warning
General Warning
Country: United States
Black Box Warning
misuse
Country: United States
Black Box Warning
vascular toxicity
Country: United States

Data from ChEMBL 36 via Core Engine